Quarterly report pursuant to Section 13 or 15(d)

Restricted Common Stock and Stock Appreciation Rights ("SARs") (Tables)

v2.4.0.8
Restricted Common Stock and Stock Appreciation Rights ("SARs") (Tables)
9 Months Ended
Sep. 30, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Stock Option Activity

The following is a summary of the Company’s stock option activity:

 

     Nine months Ended September 30,  
     2013      2012  
     Shares
Under
Options
    Weighted-
Average
Exercise
Price
     Shares
Under
Options
    Weighted-
Average
Exercise
Price
 

Options outstanding at beginning of period:

     750      $ 28.86         3,500      $ 25.67   

Exercised

     (750     28.86         (3,500     25.67   
  

 

 

   

 

 

    

 

 

   

 

 

 

Options outstanding at end of period

     —        $ —           —        $ —     
Summary of Restricted Common Stock Activity

The following is a summary of the Company’s restricted common stock activity:

 

     Nine months Ended September 30,  
     2013      2012  
     Restricted
Stock
     Weighted-
Average
Grant
Date Fair
Value
     Restricted
Stock
     Weighted-
Average
Grant
Date Fair
Value
 

Restricted common stock outstanding at beginning of period:

     27,999       $ 23.36         24,499       $ 23.36   

Issued upon exercise of stock options

     750         28.86         3,500         25.67   
  

 

 

    

 

 

    

 

 

    

 

 

 

Restricted common stock outstanding at end of period

     28,749       $ 23.76         27,999       $ 23.67   
  

 

 

    

 

 

    

 

 

    

 

 

 

Restricted common stock vested at end of period

     26,605            22,682      

Restricted common stock unvested at end of period

     2,144            5,317      
Summary of SARs Activity

The following is a summary of the Company’s SARs activity:

 

     Nine Months Ended
September 30,
 
     2013      2012  

SARs outstanding at beginning and end of period:

     28,733         27,983   
  

 

 

    

 

 

 

SARs vested at end of period

     26,589         22,666   
  

 

 

    

 

 

Formula Settlement Value and Compensation Cost Related to Non Vested Stock and SARs

The total formula-settlement value and total compensation cost related to non-vested stock and SARs are as follows:

 

     Nine Months
Ended
September 30,
 
     2013      2012  

Stock

   $ 271       $ 421   

Rights under SARs

   $ 225       $ 313  
Fair Value of Stock and SARs Vested

The total fair value of stock and SARs that vested during the nine months ended September 30 was as follows:

 

     Nine Months
Ended
September 30,
 
     2013      2012  

Stock

   $ 470       $ 695   

Rights under SARs

   $ 405       $ 566